These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6113467)

  • 1. Probucol with cholestyramine.
    Bateson MC
    Lancet; 1981 Jul; 2(8237):93. PubMed ID: 6113467
    [No Abstract]   [Full Text] [Related]  

  • 2. Cholestyramine and probucol synergism.
    Nestel PJ
    Ann Intern Med; 1982 Oct; 97(4):622. PubMed ID: 7125430
    [No Abstract]   [Full Text] [Related]  

  • 3. Probucol, cholestyramine, and serum cholesterol.
    Mann JI
    Lancet; 1981 Aug; 2(8243):422. PubMed ID: 6115188
    [No Abstract]   [Full Text] [Related]  

  • 4. The regulation of cholesterol metabolism in Ehrlich ascites tumour cells by dietary cholesterol, cholestyramine and probucol.
    Esmail A; Fears R
    Biochem Soc Trans; 1980 Oct; 8(5):545. PubMed ID: 7450213
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic effects of probucol and cholestyramine to lower serum cholesterol.
    Boyden TW; Totman L
    J Clin Pharmacol; 1981 Jan; 21(1):48-51. PubMed ID: 7217343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol and cholestyramine combination in the treatment of severe hypercholesterolemia.
    Sommariva D; Bonfiglioli D; Tirrito M; Pogliaghi I; Branchi A; Cabrini E
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):505-10. PubMed ID: 3781686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of femoral atherosclerosis in hypercholesterolemic patients during treatment with cholestyramine and probucol/placebo: Probucol Quantitative Regression Swedish Trial (PQRST): a status report.
    Walldius G; Carlson LA; Erikson U; Olsson AG; Johansson J; Mölgaard J; Nilsson S; Stenport G; Kaijser L; Lassvik C
    Am J Cardiol; 1988 Jul; 62(3):37B-43B. PubMed ID: 3293415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Probucol treatment decreases serum concentrations of diet-derived antioxidants.
    Elinder LS; Hådell K; Johansson J; Mølgaard J; Holme I; Olsson AG; Walldius G
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1057-63. PubMed ID: 7627696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of high blood cholesterol in patients with coronary heart disease].
    Nagai Y; Yamashita S
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():675-81. PubMed ID: 12735049
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro activity of probucol on cholesteryl ester transport.
    Chiesa G; Franceschini G; Sirtori CR
    Biochim Biophys Acta; 1990 Aug; 1045(3):302-4. PubMed ID: 2386803
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probucol (Lorelco) in treatment of hyperlipemia.
    Murphy BF
    JAMA; 1977 Dec; 238(23):2537-8. PubMed ID: 199758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of diet and probucol.
    Rapado A; Castrillo JM; Díaz-Curiel M
    Arch Intern Med; 1979 Sep; 139(9):1062-3. PubMed ID: 475528
    [No Abstract]   [Full Text] [Related]  

  • 13. [Pharmacology of probucol. II].
    Donatelli L
    Clin Ter; 1984 Mar; 108(6):475-95. PubMed ID: 6233067
    [No Abstract]   [Full Text] [Related]  

  • 14. [Probucol: mechanism of action (author's transl)].
    Infante R
    Nouv Presse Med; 1980 Oct; 9(40):2976-80. PubMed ID: 7443434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probucol: effects on the metabolism of low density and high density lipoproteins in moderate hypercholesterolaemia.
    Magill P; Whiting C; Hammett F; Glick I; Miller NE; Lewis B
    Artery; 1982; 10(2):88-94. PubMed ID: 7092581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacology of probucol. I].
    Donatelli L
    Clin Ter; 1984 Mar; 108(5):367-88. PubMed ID: 6232074
    [No Abstract]   [Full Text] [Related]  

  • 17. Lowered HDL cholesterol and incidence of ischaemic heart disease.
    Miettinen TA; Huttunen JK; Strandberg T; Naukkarinen V; Mattila S; Kumlin T
    Lancet; 1981 Aug; 2(8244):478. PubMed ID: 6115240
    [No Abstract]   [Full Text] [Related]  

  • 18. Combined effects of probucol and cholestyramine in familial type II hyperlipoproteinaemia.
    Pasquali R; Biso P; Parenti M; Melchionda N
    Lancet; 1981 Jun; 1(8234):1368. PubMed ID: 6113336
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of effect of probucol on serum lipoprotein(a) levels.
    Maeda S; Okuno M; Abe A; Noma A
    Atherosclerosis; 1989 Oct; 79(2-3):267-9. PubMed ID: 2597236
    [No Abstract]   [Full Text] [Related]  

  • 20. Probucol in patients resistant to the lipid-lowering effects of cholestyramine.
    Mann JI; Jelfs R; Cassels E; Barker K; Simpson HC; Carter RC
    Lancet; 1981 Feb; 1(8217):450. PubMed ID: 6110087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.